Freshfields advised SERB Pharmaceuticals on its U.S. Partnership.SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab from…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Georgio Naffaa
…
This content is for Standard 1 Year members only. LoginJoin Now